Campbell & Co. Investment Adviser »

Amicus Therapeutics shares owned by Campbell & Co. Investment Adviser

Quarter-by-quarter ownership of Amicus Therapeutics (FOLD) shares owned by Campbell & Co. Investment Adviser from 13F filings

Historical chart of Campbell & Co. Investment Adviser investment in Amicus Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Amicus Therapeutics held by Campbell & Co. Investment Adviser consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Amicus Therapeutics by Campbell & Co. Investment Adviser

Quarter filed Position value Share count Share price at filing
2024-09-30 $1.9M 176k 10.68
2024-03-31 $218k 19k 11.78
2023-09-30 $134k 11k 12.16
2022-09-30 $156k 15k 10.44
2021-03-31 $436k 44k 9.88
2019-09-30 $354k 44k 8.03

More positions owned by Campbell & Co. Investment Adviser

Workday Common Stock (WDAY)
PepsiCo Common Stock (PEP)
Msci Common Stock (MSCI)
Amphenol Corp Common Stock (APH)
Everest Group Common Stock (EG)
Cognizant Technology Solutions Common Stock (CTSH)
Tenable Holdings Common Stock (TENB)
Marsh & McLennan Cos Common Stock (MMC)
Intercontinental Exchange Common Stock (ICE)
Allegion Common Stock (ALLE)
Maximus Common Stock (MMS)
Janus Henderson Group Common Stock (JHG)
Royal Bank of Canada Common Stock (RY)
Portland General Electric Common Stock (POR)
Equifax Common Stock (EFX)

View all positions for Campbell & Co. Investment Adviser

Top funds holding Amicus Therapeutics

Vanguard Group
Perceptive Advisors
BlackRock
BlackRock
William Blair Investment Management
Henderson Group
Jpmorgan Chase & Co
State Street Corporation
Redmile Group
Palo Alto Investors
Macquarie Group
Geode Capital Management
Morgan Stanley
Bank of America Corporation
American Century Companies

View all funds holding Amicus Therapeutics